Drug trials to test a new HIV prevention method was trialled in South Africa but now the country won’t be able to afford to buy it for the people who need it most. Here’s how to change this, writes Claire Waterhouse and Lebohang Kobola.
South Africa’s diversity makes it the ideal place for pharmaceutical companies to test how well their new medicines work on different groups of people. This is a crucial bargaining chip that…
